PPT Slide
de Man et al., Hepatology, 34: 578-582 (2001)
Oral Entecavir in the treatment of patients with chronic hepatitis B virus infection
Mean HBV DNA during therapy and 1 month follow-up. (—?—) placebo, (--?--) 0.05 mg, (—?—) 0.1 mg,
(—?—) 0.5 mg, (—?—) 1.0 mg